Literature DB >> 3040624

Salivary duct carcinoma--a clinicopathologic study of 12 cases.

L E Afzelius, W R Cameron, C Svensson.   

Abstract

Salivary duct carcinoma (SDC), a recently defined malignant tumor usually of major salivary glands, has probably been included in the group of adenocarcinomas, NOS. As yet, only a few descriptions of its clinical behavior have appeared. We have found 12 cases of SDC treated at our institution since 1970 and have reviewed their presentation and course. Despite total parotidectomy in most cases and radiotherapy in all, most patients have succumbed to their tumors, six with distant metastases. SDC appears to be a highly malignant tumor requiring aggressive combined therapy for locoregional control. The high incidence of systemic spread indicates a need for effective chemotherapy on an adjuvant basis.

Entities:  

Mesh:

Year:  1987        PMID: 3040624     DOI: 10.1002/hed.2890090304

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  9 in total

1.  Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Authors:  Young Cheol Weon; Sun-Won Park; Hyung-Jin Kim; Han-Sin Jeong; Young-Hyeh Ko; In Suh Park; Sung Tae Kim; Chung Hwan Baek; Young-Ik Son
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

Review 2.  Salivary duct carcinoma: report of a case and review of the literature.

Authors:  D M Butterworth; A W Jones; B Kotecha
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 3.  Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Authors:  Roderick H W Simpson
Journal:  Head Neck Pathol       Date:  2013-07-03

4.  MR imaging of salivary duct carcinoma.

Authors:  Ken Motoori; Yumiko Iida; Yuichirou Nagai; Seiji Yamamoto; Takuya Ueda; Hiroyuki Funatsu; Hisao Ito; Okamoto Yoshitaka
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

5.  Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.

Authors:  Vijayvel Jayaprakash; Mihai Merzianu; Graham W Warren; Hassan Arshad; Wesley L Hicks; Nestor R Rigual; Maureen A Sullivan; Mukund Seshadri; James R Marshall; David M Cohan; Yujie Zhao; Anurag K Singh
Journal:  Head Neck       Date:  2013-10-07       Impact factor: 3.147

6.  Denovo High Grade Salivary Duct Carcinoma: A Case Report and Review of Literature.

Authors:  Heena Zainab; Ameena Sultana; Pramod Jahagirdar
Journal:  J Clin Diagn Res       Date:  2017-07-01

7.  Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands.

Authors:  J Y Kim; S Lee; K-J Cho; S Y Kim; S Y Nam; S-H Choi; J-L Roh; E K Choi; J H Kim; S Y Song; H S Shin; S-K Chang; S D Ahn
Journal:  Br J Radiol       Date:  2012-05-09       Impact factor: 3.039

8.  Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.

Authors:  Sebastian Adeberg; Paul Windisch; Felix Ehret; Melissa Baur; Sati Akbaba; Thomas Held; Denise Bernhardt; Matthias F Haefner; Juergen Krauss; Steffen Kargus; Christian Freudlsperger; Peter Plinkert; Christa Flechtenmacher; Klaus Herfarth; Juergen Debus; Stefan Rieken
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

9.  Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.

Authors:  Khalid Hussain Al-Qahtani; Mutahir A Tunio; Yasser Bayoumi; Venkada Manickam Gurusamy; Fahad Ahmed A Bahamdain; Hanadi Fatani
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-05-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.